| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |